OA
Orbimed Advisors LLC cut its LXEO stake below 5%
Orbimed Advisors LLC reported owning 3.9% of Lexeo Therapeutics, Inc. (LXEO) (3,203,050 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G